Fig. 3: Kaplan−Meier analysis of time to progression among patients with isolated del(20q). | Blood Cancer Journal

Fig. 3: Kaplan−Meier analysis of time to progression among patients with isolated del(20q).

From: The significance of genetic mutations and their prognostic impact on patients with incidental finding of isolated del(20q) in bone marrow without morphologic evidence of a myeloid neoplasm

Fig. 3

a The time to progression and/or death among patients with mutation(s) (red) was 32.8 months and among those without mutation (blue) was 50.5 months (Log-rank P = 0.03). b Patients with mutation(s) (red) had a significantly higher risk of progression to a myeloid neoplasm in comparison to those without mutation (blue) (Log-rank P < 0.0001). c There was no significant difference in progression to a myeloid neoplasm among patients with one mutation (red) versus >1 mutations (green) (Log-rank P = 0.74).

Back to article page